openPR Logo
Press release

Abdominal Aortic Aneurysm Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies involved by DelveInsight | Merck Serono, AstraZeneca, Endologix LLC, Cardinal Health, Cook Medical

10-01-2024 03:54 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Abdominal Aortic Aneurysm Pipeline Forecast 2024: FDA

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Abdominal Aortic Aneurysm pipeline constitutes key companies continuously working towards developing Abdominal Aortic Aneurysm treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Abdominal Aortic Aneurysm Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Abdominal Aortic Aneurysm Market.

The Abdominal Aortic Aneurysm Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Abdominal Aortic Aneurysm Pipeline Report:

*
Companies across the globe are diligently working toward developing novel Abdominal Aortic Aneurysm treatment therapies with a considerable amount of success over the years. Abdominal Aortic Aneurysm Key players such as - Merck Serono, AstraZeneca, Endologix LLC, Cardinal Health, Cook Medical, W. L. Gore & Associates, Inc., Medtronic, MicroPort Scientific Corporation, Artivion, Inc., Lifetech Scientific (Shenzhen) Co., Ltd., Lombard Medical, Endologix LLC, Latecba SA, Nectero Medical, Cardiatis, SA, Hangzhou Endonom Medtech Co., Ltd., and others, and others, are developing therapies for the Abdominal Aortic Aneurysm treatment

*
Abdominal Aortic Aneurysm Emerging therapies such as - Ticagrelor, Metformin Glucophage, Abdominal Aortic Aneurysm Stent Graft System, Fenestrated AlturaTM FEVAR Stent Graft, Seta Latecba Stent Grafts, Nectero EAST Registered , Bifurcated MFM Registered , and others, and others are expected to have a significant impact on the Abdominal Aortic Aneurysm market in the coming years.

*
In January 2024, Arizona-based Nectro Medical has initiated a Phase II/III trial evaluating the safety and efficacy of its endovascular aneurysm stabilisation treatment (Nectero EAST). Nectero EAST is a single-use, endovascular system made up of a dual-balloon delivery catheter and stabiliser mixture of pentagalloyl glucose (PGG). The PGG, when administered locally, can bind to elastin and collagen to potentially strengthen the aortic wall. Animal studies have shown that PGG can hinder the development of abdominal aortic aneurysm (AAA).

Abdominal Aortic Aneurysm Overview

Abdominal Aortic Aneurysm (AAA) is a localized enlargement of the abdominal aorta such that the diameter is greater than 3 cm or more than 50% larger than usual. It occurs when atherosclerosis or plaque buildup causes the walls of the abdominal aorta to become weak and bulge outward like a balloon.

Get a Free Sample PDF Report to know more about Abdominal Aortic Aneurysm Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/abdominal-aortic-aneurysm-pipeline-insight [https://www.delveinsight.com/report-store/abdominal-aortic-aneurysm-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Abdominal Aortic Aneurysm Pipeline Therapeutics Assessment

*
Abdominal Aortic Aneurysm Assessment by Product Type

*
Abdominal Aortic Aneurysm By Stage and Product Type

*
Abdominal Aortic Aneurysm Assessment by Route of Administration

*
Abdominal Aortic Aneurysm By Stage and Route of Administration

*
Abdominal Aortic Aneurysm Assessment by Molecule Type

*
Abdominal Aortic Aneurysm by Stage and Molecule Type

DelveInsight's Abdominal Aortic Aneurysm Report covers around products under different phases of clinical development like

*
Late-stage products (Phase III)

*
Mid-stage products (Phase II)

*
Early-stage product (Phase I)

*
Pre-clinical and Discovery stage candidates

*
Discontinued & Inactive candidates

*
Route of Administration

Some of the key companies in the Abdominal Aortic Aneurysm Therapeutics Market include:

Key companies developing therapies for Abdominal Aortic Aneurysm treatment are - CARDIATIS S.A., CARDINAL HEALTH, INC., COOK MEDICAL, INC., ENDOLOGIX, INC., jotec gmbh, LOMBARD MEDICAL, INC., MEDTRONIC PLC, nano endoluminal sa, TERUMO CORPORATION, W. L. GORE & ASSOCIATES, INC., and others.

Download Sample PDF Report to know more about Abdominal Aortic Aneurysm drugs and therapies [https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Emerging Abdominal Aortic Aneurysm Drugs and devices Under Different Phases of Clinical Development Include:

*
Metformin Glucophage: Merck Serono

*
Ticagrelor: AstraZeneca

*
Abdominal Aortic Aneurysm Stent Graft System: Lifetech Scientific

*
Fenestrated AlturaTM FEVAR Stent Graft: Lombard Medical

*
Seta Latecba Stent Grafts: Latecba SA

*
Nectero EAST Registered : Nectero Medical

*
Bifurcated MFM Registered : Cardiatis

Abdominal Aortic Aneurysm Pipeline Analysis:

The Abdominal Aortic Aneurysm pipeline report provides insights into

*
The report provides detailed insights about companies that are developing therapies for the treatment of Abdominal Aortic Aneurysm with aggregate therapies developed by each company for the same.

*
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Abdominal Aortic Aneurysm Treatment.

*
Abdominal Aortic Aneurysm key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

*
Abdominal Aortic Aneurysm Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Abdominal Aortic Aneurysm market.

The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Further Abdominal Aortic Aneurysm product details are provided in the report. Download the Abdominal Aortic Aneurysm pipeline report to learn more about the emerging Abdominal Aortic Aneurysm therapies [https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Scope of Abdominal Aortic Aneurysm Pipeline Drug Insight

*
Coverage: Global

*
Key Abdominal Aortic Aneurysm Companies: Merck Serono, AstraZeneca, Endologix LLC, Cardinal Health, Cook Medical, W. L. Gore & Associates, Inc., Medtronic, MicroPort Scientific Corporation, Artivion, Inc., Lifetech Scientific (Shenzhen) Co., Ltd., Lombard Medical, Endologix LLC, Latecba SA, Nectero Medical, Cardiatis, SA, Hangzhou Endonom Medtech Co., Ltd., and others, and others

*
Key Abdominal Aortic Aneurysm Therapies: Ticagrelor, Metformin Glucophage, Abdominal Aortic Aneurysm Stent Graft System, Fenestrated AlturaTM FEVAR Stent Graft, Seta Latecba Stent Grafts, Nectero EAST Registered , Bifurcated MFM Registered , and others, and others

*
Abdominal Aortic Aneurysm Therapeutic Assessment: Abdominal Aortic Aneurysm current marketed and Abdominal Aortic Aneurysm emerging therapies

*
Abdominal Aortic Aneurysm Market Dynamics: Abdominal Aortic Aneurysm market drivers and Abdominal Aortic Aneurysm market barriers

Request for Sample PDF Report for Abdominal Aortic Aneurysm Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1

Abdominal Aortic Aneurysm Report Introduction

2

Abdominal Aortic Aneurysm Executive Summary

3

Abdominal Aortic Aneurysm Overview

4

Abdominal Aortic Aneurysm- Analytical Perspective In-depth Commercial Assessment

5

Abdominal Aortic Aneurysm Pipeline Therapeutics

6

Abdominal Aortic Aneurysm Late Stage Products (Phase II/III)

7

Abdominal Aortic Aneurysm Mid Stage Products (Phase II)

8

Abdominal Aortic Aneurysm Early Stage Products (Phase I)

9

Abdominal Aortic Aneurysm Preclinical Stage Products

10

Abdominal Aortic Aneurysm Therapeutics Assessment

11

Abdominal Aortic Aneurysm Inactive Products

12

Company-University Collaborations (Licensing/Partnering) Analysis

13

Abdominal Aortic Aneurysm Key Companies

14

Abdominal Aortic Aneurysm Key Products

15

Abdominal Aortic Aneurysm Unmet Needs

16

Abdominal Aortic Aneurysm Market Drivers and Barriers

17

Abdominal Aortic Aneurysm Future Perspectives and Conclusion

18

Abdominal Aortic Aneurysm Analyst Views

19

Appendix

20

About DelveInsight

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=abdominal-aortic-aneurysm-pipeline-forecast-2024-fda-approvals-therapies-and-leading-companies-involved-by-delveinsight-merck-serono-astrazeneca-endologix-llc-cardinal-health-cook-medical]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Abdominal Aortic Aneurysm Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies involved by DelveInsight | Merck Serono, AstraZeneca, Endologix LLC, Cardinal Health, Cook Medical here

News-ID: 3674679 • Views:

More Releases from ABNewswire

DermaStation Skin Clinic strengthens its hair loss treatment offering
DermaStation Skin Clinic strengthens its hair loss treatment offering
The Delhi-based skin clinic offers the most advanced hair loss treatment that ensures healthier hair regrowth and improved density. In view of the growing concerns over progressive hair fall and pattern baldness, DermaStation, a popular dermatology clinic in Delhi, enhances its Platelet Rich Plasma Therapy for better and lasting results. The move to offer advanced platelet rich plasma treatment [https://www.dermastation.com/blog/platelet-rich-plasma-treatment-in-delhi-a-complete-guide-to-prp-therapy/] and comprehensive treatment is in line with DermaStation's commitment to provide finest
Grand Prairie-Based Cannon System Design Addresses Rising IT Networking Demands Across DFW Region
Grand Prairie-Based Cannon System Design Addresses Rising IT Networking Demands …
Cannon System Design, a Grand Prairie technology firm established in 2019, provides IT infrastructure and security solutions across the DFW region, serving schools, hospitals, churches, and businesses with local expertise. As businesses and institutions across the Dallas-Fort Worth area face increasing technological demands, Cannon System Design [https://www.cannonsystem.design/] has positioned itself as a reliable provider of comprehensive technology solutions. Since launching operations in 2019, the Grand Prairie-based company has been serving schools,
CLAIMED BY GOD DESIGNS Announces 2026 Expansion Following Breakthrough Holiday Performance.
CLAIMED BY GOD DESIGNS Announces 2026 Expansion Following Breakthrough Holiday P …
After achieving record holiday sales, CLAIMED BY GOD DESIGNS prepares major 2026 expansion plans to meet growing demand for faith-based fashion that empowers believers worldwide. The brand's scripture-rooted designs and innovative approach to Christian lifestyle retail continue attracting new generations of faithful consumers seeking authentic, stylish expressions of belief. CLAIMED BY GOD DESIGNS is leveraging extraordinary holiday season success to launch ambitious expansion plans for 2026, positioning the brand to meet
Burbank Chimney Services Advises Homeowners on Year-Round Chimney Safety
Burbank Chimney Services Advises Homeowners on Year-Round Chimney Safety
Burbank Chimney Services is advising homeowners to take a proactive approach to chimney safety during the winter heating season, when increased fireplace use can reveal underlying issues within chimney and ventilation systems. Industry professionals say colder temperatures and heavier usage often make debris accumulation, moisture intrusion, and airflow problems more noticeable and potentially hazardous. Homeowners scheduling a Chimney Sweep [https://burbankchimneyservices.com/] are encouraged to arrange inspections during winter months, when creosote buildup,

All 5 Releases


More Releases for Abdominal

Intra-Abdominal Pressure Measurement Devices Market
Intra-abdominal pressure (IAP) measurement is a critical aspect of healthcare, particularly in the intensive care setting. The accurate assessment of IAP provides valuable insights into a patient's physiological condition, especially in individuals with critical illnesses or undergoing major surgeries. IAP is defined as the pressure within the abdominal cavity, and an increased IAP can have significant implications on a patient's health, affecting multiple organ systems. As a result, the demand
Intra-Abdominal Pressure Measurement Devices Market: An Overview
Intra-abdominal pressure (IAP) measurement is an essential diagnostic tool used in clinical settings to assess and monitor the pressure inside the abdominal cavity. IAP plays a crucial role in understanding and managing conditions such as intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS), which can lead to significant complications if left untreated. Over the years, the technology used for measuring IAP has evolved, and with growing awareness of its importance
Max Flex Core abdominal stimulator Review: Best EMS abdominal stimulator Canada/ …
Max Flex Core abdominal stimulator Review: Best EMS abdominal stimulator Canada/United States Max Flex Core abdominal stimulator is an abs stimulator designed to help strengthen and tone the abdominal muscles. The device works by delivering electrical impulses to the muscles, causing them to contract and relax, simulating the effect of exercise. This tool provides numerous benefits to the user as it helps to activate the muscles. Individuals who have difficulty
Intra-Abdominal Pressure Measurement Devices Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Intra-Abdominal Pressure Measurement Devices Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key
Abdominal Pain Drugs Market - Trends and Forecast
Global abdominal pain drugs market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing with a CAGR of 4.90% in the above-mentioned research forecast period. Increasing prevalence of patients and investments in research and development both from public and government sectors are the factors responsible for the growth of this market. Increasing awareness among people, increase in
Abdominal Closure System Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Abdominal Closure System Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Abdominal Closure System players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Abdominal Closure System with respect